Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interface Biologics
Toronto, Ontario, Canadaca.linkedin.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Commercial
01
Overview
Interface Biologics' Endexo technology is used in FDA-cleared vascular access catheters (BioFlo PICCs, Ports, and Dialysis Catheter commercialized by AngioDynamics; also used in Fresenius Medical Care’s chronic dialysis systems). These products are on market; further preclinical/clinical activity is primarily via partnerships for new device coatings
- Therapeutic areas
- Infectious DiseasesCardiovascular
- Modalities
- DevicePolymer-drug conjugate therapy
- Industry
- Chemicals & Materials
02
Partnerships
AngioDynamics (Endexo technology licensed for BioFlo line)Fresenius Medical Care (Endexo in chronic dialysis systems)Qualimed (joint venture for Kinesyx technology)
Beyond the preview
Go deeper on Interface Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Interface Biologics.